DUBLIN--(BUSINESS WIRE)--The "Regenerative Medicine Market by Product Type, Material, and Application - Global Opportunity Analysis and Industry Forecast, 2017-2023" report has been added to ResearchAndMarkets.com's offering.
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023.
The major factors that boost the market growth include technological advancements in tissue and organ regeneration, increase in prevalence of chronic diseases and trauma emergencies, prominent potential of nanotechnology, and emergence of stem cell technology. In addition, rise in degenerative diseases and shortage of organs for transplantation are expected to fuel the growth of the market. Moreover, utilization of nanomaterials in wound care, drug delivery, and immunomodulation has opened numerous growth avenues for the regenerative medicines market.
The global regenerative medicine market is segmented based on product type, material, application, and geography. Based on product type, the market is classified into cell therapy, gene therapy, tissue engineering, and small molecule & biologic. Depending on material, it is categorized into synthetic material, biologically derived material, genetically engineered material, and pharmaceutical. Synthetic material is further divided into biodegradable synthetic polymer, scaffold, artificial vascular graft material, and hydrogel material. Biologically derived material is further bifurcated into collagen and xenogenic material. Genetically engineered material is further segmented into deoxyribonucleic acid, transfection vector, genetically manipulated cell, three-dimensional polymer technology, transgenic, fibroblast, neural stem cell, and gene-activated matrices. Pharmaceutical is further divided into small molecule and biologic.
- Stryker Corporation
- Zimmer Biomet Holdings, Inc.
- Medtronic Plc.
- Athersys, Inc.
- U.S. Stem Cell, Inc.
- Organogenesis, Inc.
- Integra Lifesciences Holdings Corporation
- Acelity Holdings, Inc.
- Isto Biologics
- CryoLife, Inc.
Key Topics Covered:
2: Executive Summary
3: Market Overview
4: Regenerative Medicine Market, By Product Type
5: Regenerative Medicine Market, By Material
6: Regenerative Medicine Market, By Application
7: Regenerative Medicine Market, By Region
8: Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/qd5xbt/global?w=4